Search terms
Results 41 - 50 of 151 - ordered by :
Pages: 1 ... 2 3 4 5 6 7 8 ... 16

5 ,  ,  ,  ,  ,  ,  ,  ,  .  Randomized, double-blind, placebo-controlled study to evaluate the effect of two dosing regimens of darbepoetin alfa in patients with heart ...

European Heart Journal, van der Meer, Peter, Januzzi, James L., van Veldhuisen, Dirk J.

Date : 01/11/2008 Item size : 99449 bytes

Abstract Aims An increased pulse pressure (PP) has consistently predicted increased cardiovascular morbidity and mortality in cardiovascular risk patients and mild chronic heart failure ...

European Heart Journal, Voors, Adriaan A., Petrie, Colin J., Petrie, Mark C., Charlesworth, Andrew, Hillege, Hans L., Zijlstra, Felix, McMurray, John J., van Veldhuisen, Dirk J.

Date : 01/09/2005 Item size : 172421 bytes

Biomarkers of renal injury and function: diagnostic, prognostic and therapeutic implications in heart failure Abstract Heart failure guidelines suggest evaluating renal function as a routine work-up ...

European Heart Journal, van Veldhuisen, Dirk J., Ruilope, Luis M., Maisel, Alan S., Damman, Kevin

Date : 01/09/2016 Item size : 498702 bytes

The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Citation Kenneth Dickstein, Alain Cohen-Solal, Gerasimos Filippatos, ...

European Heart Journal, Dickstein, Kenneth, Cohen-Solal, Alain, Filippatos, Gerasimos, McMurray, John J.V., Ponikowski, Piotr, Poole-Wilson, Philip Alexander, Strömberg, Anna, van Veldhuisen, Dirk ...

Date : 01/03/2010

Methods and results In 8592 subjects of the Prevention of Renal and Vascular End-stage Disease (PREVEND), a community-based, middle-aged cohort study, we performed cause-specific hazard analyses to ...

European Heart Journal, Brouwers, Frank P., de Boer, Rudolf A., van der Harst, Pim, Voors, Adriaan A., Gansevoort, Ron T., Bakker, Stephan J., Hillege, Hans L., van Veldhuisen, Dirk J., van Gilst, ...

Date : 14/05/2013 Item size : 289303 bytes

See page 2577 for the editorial comment on this article (doi:10.1093/eurheartj/ehq307) Introduction Erythropoietin (EPO) is commonly known as an effective treatment for anaemia, partly caused by an ...

European Heart Journal, Voors, Adriaan A., Belonje, Anne M.S., Zijlstra, Felix, Hillege, Hans L., Anker, Stefan D., Slart, Riemer H.J.A., Tio, René A., van ‘t Hof, Arnoud, Jukema, J. Wouter, ...

Date : 01/11/2010 Item size : 280692 bytes

Several controlled trials demonstrated that combination therapy can have additional benefits in hypertensive patients, in chronic heart failure patients, and in both diabetic and non-diabetic ...

European Heart Journal, van de Wal, Ruud M.A., van Veldhuisen, Dirk J., van Gilst, Wiek H., Voors, Adriaan A.

Date : 01/11/2005 Item size : 206620 bytes

Associations persisted after adjustment for demographics, risk factors for coronary artery disease, co-morbidity, Killip class, and baseline BDI score. See page 2607 for the editorial comment on ...

European Heart Journal, van Melle, Joost P., de Jonge, Peter, Ormel, Johan, Crijns, Harry J.G.M., van Veldhuisen, Dirk J., Honig, Adriaan, Schene, Aart H., van den Berg, Maarten P.

Date : 01/12/2005 Item size : 186545 bytes

Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol or Metoprolol European Trial (COMET): randomised controlled trial.

European Heart Journal, van Veldhuisen, Dirk J., Crijns, Harry J.G.M., van den Berg, Maarten P.

Date : 01/01/2006 Item size : 84892 bytes

Therapeutic options for patients with breast cancer have improved, and many patients with early breast cancer receive adjuvant systemic therapy including anthracyclines, taxanes, trastuzumab, ...

European Heart Journal, van der Meer, Peter, Gietema, Jourik A., Suter, Thomas M., van Veldhuisen, Dirk J.

Date : 01/06/2016